Semler Scientific, Inc. (SMLR)

Market Cap	639.67M
Revenue (ttm)	49.23M
Net Income (ttm)	-29.88M
Shares Out	17.70M
EPS (ttm)	-3.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,239,435
Open	36.71
Previous Close	31.94
Day's Range	33.60 - 37.10
52-Week Range	21.77 - 81.56
Beta	1.43
Analysts	Strong Buy
Price Target	71.00 (+96.46%)
Earnings Date	Aug 4, 2025

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, ind...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 79
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2024, Semler Scientific's revenue was $56.29 million, a decrease of -17.44% compared to the previous year's $68.18 million. Earnings were $40.90 million, an increase of 98.70%.

Analyst Forecast

According to one analyst, the rating for SMLR stock is "Strong Buy" and the 12-month stock price forecast is $71.0.

Price Target

$71.0

(96.46% upside)

Analyst Consensus: Strong Buy